American Medical Association (AMA)

The American Medical Association (AMA) is the largest professional association and lobbying group of physicians and medical students. The AMA mission is to promote the art and science of medicine and the betterment of public health. The association represents physicians with a unified voice in courts and legislative bodies across the nation, removing obstacles that interfere with patient care, leading efforts to prevent chronic disease and confront public health crises, and driving the future of medicine to tackle the biggest challenges in healthcare.

AMA House of Delegates helps cardiology groups influence healthcare policies
American College of Cardiology Board of Governors Chair David E. Winchester, MD, MS, examines the many benefits of working with the American Medical Association House of Delegates to bring about significant change.
AMA to advocate for improved Medicare payments for office-based labs
SCAI and other healthcare groups want changes made to how healthcare providers are paid after performing office-based lab procedures. "As much as we love delivering care as doctors, if we are losing money doing something, we cannot sustain it," one cardiologist explained.
AMA President highlights growing crisis facing U.S. physicians
American Medical Association President Bruce Scott, MD, explains some of the key issues facing physicians, including burnout, growing medical staffing shortages, doctors leaving rural areas, increasing patients and declining Medicare payments.
ACC backs AMA resolution to boost lung cancer and heart disease screenings in smokers with low-dose CT scans
Former American College of Cardiology president Kim Allan Williams, Sr., MD, an ACC delegate to the American Medical Association House of Delegates, discusses an AMA resolution aimed at improving public awareness of low-dose CT lung cancer exams that can screen for coronary artery calcium at the same time.
AMA brainstorms on key topics impacting healthcare
"With significantly strengthened penalties, standardized reporting requirements and unprecedented enforcement commitments, the regulatory landscape has dramatically shifted," the AMA wrote.

AMA maps out 5-point ‘road to recovery’ for frazzled physicians

Supporting telehealth, reforming Medicare, fixing the prior authorization process—these are three of five goals the American Medical Association is pursuing in an expansive new program.

Prior authorization under fire in Inspector General investigation

An investigation from the Office of the Inspector General (OIG) regarding prior authorization requirements in Medicare Advantage (MA) plans revealed concerns about access to care.

AMA appoints new editor of JAMA

The American Medical Association (AMA) has named Kirsten Bibbins-Domingo, MD, PhD, MAS, as its next editor for the Journal of the American Medical Association (JAMA) and JAMA Network.

Healthcare groups urge Congress to extend hospital-at-home waivers

Dozens of healthcare groups have banded together to ask Congress to extend waivers for hospital care at home that were granted during the COVID-19 pandemic.

AMA launches initiative to support more equitable health innovation

The AMA created initiative to supports leading industry stakeholders in committing to equitable health innovation opportunities targeted to improving health outcomes in historically marginalized communities.

Prior authorization burdens are increasing

Healthcare leaders agree prior authorization burdens are increasing.

About 100 medical societies ask Congress to be involved in Congressional efforts to reform Medicare

Nearly 100 professional healthcare societies have asked Congress to include them in any discussions related to Medicare reform.

Supreme Court allows CMS vaccine mandate for healthcare workers, blocks rule for large businesses

The American Hospital Association praised the court's decision to allow the mandate on federally funded healthcare facilities and said it will work to balance potential workforce shortages.

Around the web

Cardiovascular Business

Eli Lilly to acquire gene-editing specialists focused on CVD for up to $1.3B

The company has agreed to acquire Verve Therapeutics for an upfront payment of approximately $1 billion. The total could increase significantly, however, if certain milestones are met. One of Verve's biggest gene therapies has already received the FDA's fast track designation.

Cardiovascular Business

AMA House of Delegates helps cardiology groups influence healthcare policies

American College of Cardiology Board of Governors Chair David E. Winchester, MD, MS, examines the many benefits of working with the American Medical Association House of Delegates to bring about significant change.

Cardiovascular Business

Smaller revenues, less growth: In US, tariffs may create headaches for $34.5B cardiovascular device market

“Without a more concrete and stable policy on these tariffs from the current American administration, it is likely that most manufacturers will be forced to continuously change their internal forecasts and production plans," one analyst said.